食品科学 ›› 2026, Vol. 47 ›› Issue (10): 1-18.doi: 10.7506/spkx1002-6630-20260303-027

• 专家约稿 •    下一篇

工程益生菌短链脂肪酸的合成生物学设计:从代谢强化到智能调控

江凌,刘振磊,朱政明   

  1. (1.南京工业大学食品与轻工学院,江苏 南京 211816;2.南京工业大学 材料化学工程国家重点实验室,江苏 南京 211816;3.南京工业大学生物与制药工程学院,江苏 南京 211816)
  • 出版日期:2026-05-25 发布日期:2026-06-10
  • 基金资助:
    国家自然科学基金面上项目(32472489);国家自然科学基金专项项目(32541093); 江苏省合成生物基础研究中心项目(BK20233003)

Synthetic Biology Design of Engineered Probiotics for Short-Chain Fatty Acid Production: from Metabolic Enhancement to Smart Regulation

JIANG Ling, LIU Zhenlei, ZHU Zhengming   

  1. (1. College of Food and Light Industry, Nanjing Tech University, Nanjing 211816, China; 2. State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech University, Nanjing 211816, China; 3. College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China)
  • Online:2026-05-25 Published:2026-06-10

摘要: 短链脂肪酸(short-chain fatty acids,SCFAs)作为肠道微生物群发酵膳食纤维等底物产生的关键代谢产物,在维持肠道屏障功能、调节免疫平衡及促进身体健康方面发挥着重要作用。本综述旨在探索工程化食品微生物(特别是益生菌)作为新型“生物工厂”,以实现SCFAs高效、精准合成的策略。本文首先阐述了理想工程化底盘菌株的核心筛选标准,包括其在应用中的安全性、肠道环境下的稳健性以及遗传可操作性。随后,详细介绍了通过挖掘与强化限速酶、酶工程智能化改造以及人工智能驱动的代谢网络优化技术,显著提升食品微生物SCFAs合成效率的策略。本文还探讨了如何整合生物传感器与成簇规律间隔短回文重复序列动态调控系统,实现SCFAs在肠道微生态中的按需、精准调控。此外,展望了工程化食品微生物在两大方向的应用前景:一是体外食品工业生物制造,即利用工程菌株在发酵罐中高效生产短链脂肪酸作为食品配料或添加剂,该路径技术成熟度较高,监管路径相对清晰;二是体内活菌治疗,即直接摄入工程益生菌在肠道原位合成短链脂肪酸,该路径在个性化营养干预和肠道健康管理中潜力巨大,但面临更高的安全性评估与监管挑战。

关键词: 短链脂肪酸;工程益生菌;生物传感器;干扰型/激活型成簇规律间隔短回文重复序列;动态调控

Abstract: Short-chain fatty acids (SCFAs), as key metabolites produced by the intestinal microbiota from the fermentation of dietary fiber and other substrates, play a crucial role in maintaining intestinal barrier function, regulating immune balance, and promoting systemic health. This review explores strategies for utilizing engineered food microorganisms (particularly probiotics) as novel “bio-factories” to achieve efficient and precise synthesis of SCFAs. This review outlines the core selection criteria for ideal engineered chassis strains, including their safety for application, robustness in the intestinal environment, and genetic tractability. It then details strategies for significantly enhancing the efficiency of SCFA synthesis in food microorganisms such as discovery and engineering of rate-limiting enzymes, intelligent enzyme engineering modifications, and artificial intelligence-driven metabolic network optimization. Furthermore, this review discusses how to integrate biosensors and clustered regularly interspaced short palindromic repeats-based dynamic regulation systems to achieve on-demand and precise modulation of SCFAs within the intestinal microecology. The application prospects of engineered food microorganisms are discussed in two major directions: First, in vitro food industrial biomanufacturing, i.e., utilizing engineered strains to efficiently produce SCFAs in fermentation systems as food ingredients or additives; this pathway exhibits relatively high technical maturity and a relatively clear regulatory framework. Second, in vivo live biotherapeutics, i.e., direct ingestion of engineered probiotics to in situ synthesize SCFAs in the gut. This pathway holds significant potential for personalized nutritional intervention and gut health management, but faces greater challenges in safety assessment and regulation.

Key words: short-chain fatty acids; engineered probiotics; biosensors; clustered regularly interspaced short palindromic repeats interference/activation; dynamic regulation

中图分类号: